Non-Hormone Drug Eases Menopausal Symptoms
A real-world study presented at the ENDO 2026 meeting indicates that the non-hormonal drug fezolinetant effectively reduces hot flashes, anxiety, and depression in menopausal women. The findings suggest that non-hormonal treatments provide significant relief comparable to clinical trial results.
Why it matters
This research offers women more diverse and effective options for managing menopausal symptoms without the use of hormones.
CHICAGO - The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.
The article reports on medical research findings in a neutral, informative manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in